Ignite Creation Date:
2024-05-05 @ 9:33 PM
Last Modification Date:
2024-10-26 @ 10:06 AM
Study NCT ID:
NCT00910624
Status:
COMPLETED
Last Update Posted:
2021-02-08
First Post:
2009-05-28
Brief Title:
Boceprevir Treatment in Participants With Chronic Hepatitis C Genotype 1 Deemed Nonresponders to PeginterferonRibavirin P05514
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-06-22
Start Date Type:
ACTUAL
Primary Completion Date:
2012-12-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-12-07
Completion Date Type:
ACTUAL
First Submit Date:
2009-05-28
First Submit QC Date:
May 28 2009
Study First Post Date:
2009-06-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2013-11-19
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-15
Last Update Post Date:
2021-02-08
Last Update Post Date Type:
ACTUAL